Global Opioids Drug Market Research Report 2023(Status and Outlook)
Report Overview
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
The Global Opioids Drug Market Size was estimated at USD 10240.00 million in 2022 and is projected to reach USD 9017.38 million by 2029, exhibiting a CAGR of -1.80% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Opioids Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Opioids Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Opioids Drug market in any manner.
Global Opioids Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
Market Segmentation (by Type)
Oxycodone
Hydromorphone
Codeine
Fentanyl
Market Segmentation (by Application)
Functional Foods
Functional Beverages
Dietary Supplements
Animal Nutrition (for Meat and Milk)
Cosmeceuticals
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Opioids Drug Market
Overview of the regional outlook of the Opioids Drug Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Opioids Drug
- 1.2 Key Market Segments
- 1.2.1 Opioids Drug Segment by Type
- 1.2.2 Opioids Drug Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Opioids Drug Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Opioids Drug Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Opioids Drug Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Opioids Drug Market Competitive Landscape
- 3.1 Global Opioids Drug Sales by Manufacturers (2018-2023)
- 3.2 Global Opioids Drug Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Opioids Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Opioids Drug Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Opioids Drug Sales Sites, Area Served, Product Type
- 3.6 Opioids Drug Market Competitive Situation and Trends
- 3.6.1 Opioids Drug Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Opioids Drug Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Opioids Drug Industry Chain Analysis
- 4.1 Opioids Drug Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Opioids Drug Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Opioids Drug Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Opioids Drug Sales Market Share by Type (2018-2023)
- 6.3 Global Opioids Drug Market Size Market Share by Type (2018-2023)
- 6.4 Global Opioids Drug Price by Type (2018-2023)
- 7 Opioids Drug Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Opioids Drug Market Sales by Application (2018-2023)
- 7.3 Global Opioids Drug Market Size (M USD) by Application (2018-2023)
- 7.4 Global Opioids Drug Sales Growth Rate by Application (2018-2023)
- 8 Opioids Drug Market Segmentation by Region
- 8.1 Global Opioids Drug Sales by Region
- 8.1.1 Global Opioids Drug Sales by Region
- 8.1.2 Global Opioids Drug Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Opioids Drug Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Opioids Drug Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Opioids Drug Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Opioids Drug Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Opioids Drug Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Teva
- 9.1.1 Teva Opioids Drug Basic Information
- 9.1.2 Teva Opioids Drug Product Overview
- 9.1.3 Teva Opioids Drug Product Market Performance
- 9.1.4 Teva Business Overview
- 9.1.5 Teva Opioids Drug SWOT Analysis
- 9.1.6 Teva Recent Developments
- 9.2 Purdue Pharma
- 9.2.1 Purdue Pharma Opioids Drug Basic Information
- 9.2.2 Purdue Pharma Opioids Drug Product Overview
- 9.2.3 Purdue Pharma Opioids Drug Product Market Performance
- 9.2.4 Purdue Pharma Business Overview
- 9.2.5 Purdue Pharma Opioids Drug SWOT Analysis
- 9.2.6 Purdue Pharma Recent Developments
- 9.3 Mallinckrodt
- 9.3.1 Mallinckrodt Opioids Drug Basic Information
- 9.3.2 Mallinckrodt Opioids Drug Product Overview
- 9.3.3 Mallinckrodt Opioids Drug Product Market Performance
- 9.3.4 Mallinckrodt Business Overview
- 9.3.5 Mallinckrodt Opioids Drug SWOT Analysis
- 9.3.6 Mallinckrodt Recent Developments
- 9.4 Amneal Pharma
- 9.4.1 Amneal Pharma Opioids Drug Basic Information
- 9.4.2 Amneal Pharma Opioids Drug Product Overview
- 9.4.3 Amneal Pharma Opioids Drug Product Market Performance
- 9.4.4 Amneal Pharma Business Overview
- 9.4.5 Amneal Pharma Opioids Drug SWOT Analysis
- 9.4.6 Amneal Pharma Recent Developments
- 9.5 Collegium
- 9.5.1 Collegium Opioids Drug Basic Information
- 9.5.2 Collegium Opioids Drug Product Overview
- 9.5.3 Collegium Opioids Drug Product Market Performance
- 9.5.4 Collegium Business Overview
- 9.5.5 Collegium Opioids Drug SWOT Analysis
- 9.5.6 Collegium Recent Developments
- 9.6 Jandamp;J
- 9.6.1 Jandamp;J Opioids Drug Basic Information
- 9.6.2 Jandamp;J Opioids Drug Product Overview
- 9.6.3 Jandamp;J Opioids Drug Product Market Performance
- 9.6.4 Jandamp;J Business Overview
- 9.6.5 Jandamp;J Recent Developments
- 9.7 Endo
- 9.7.1 Endo Opioids Drug Basic Information
- 9.7.2 Endo Opioids Drug Product Overview
- 9.7.3 Endo Opioids Drug Product Market Performance
- 9.7.4 Endo Business Overview
- 9.7.5 Endo Recent Developments
- 9.8 Pfizer
- 9.8.1 Pfizer Opioids Drug Basic Information
- 9.8.2 Pfizer Opioids Drug Product Overview
- 9.8.3 Pfizer Opioids Drug Product Market Performance
- 9.8.4 Pfizer Business Overview
- 9.8.5 Pfizer Recent Developments
- 9.9 INSYS
- 9.9.1 INSYS Opioids Drug Basic Information
- 9.9.2 INSYS Opioids Drug Product Overview
- 9.9.3 INSYS Opioids Drug Product Market Performance
- 9.9.4 INSYS Business Overview
- 9.9.5 INSYS Recent Developments
- 9.10 Mylan
- 9.10.1 Mylan Opioids Drug Basic Information
- 9.10.2 Mylan Opioids Drug Product Overview
- 9.10.3 Mylan Opioids Drug Product Market Performance
- 9.10.4 Mylan Business Overview
- 9.10.5 Mylan Recent Developments
- 9.11 Hikma
- 9.11.1 Hikma Opioids Drug Basic Information
- 9.11.2 Hikma Opioids Drug Product Overview
- 9.11.3 Hikma Opioids Drug Product Market Performance
- 9.11.4 Hikma Business Overview
- 9.11.5 Hikma Recent Developments
- 9.12 Egalet
- 9.12.1 Egalet Opioids Drug Basic Information
- 9.12.2 Egalet Opioids Drug Product Overview
- 9.12.3 Egalet Opioids Drug Product Market Performance
- 9.12.4 Egalet Business Overview
- 9.12.5 Egalet Recent Developments
- 10 Opioids Drug Market Forecast by Region
- 10.1 Global Opioids Drug Market Size Forecast
- 10.2 Global Opioids Drug Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Opioids Drug Market Size Forecast by Country
- 10.2.3 Asia Pacific Opioids Drug Market Size Forecast by Region
- 10.2.4 South America Opioids Drug Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Opioids Drug by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Opioids Drug Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Opioids Drug by Type (2024-2029)
- 11.1.2 Global Opioids Drug Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Opioids Drug by Type (2024-2029)
- 11.2 Global Opioids Drug Market Forecast by Application (2024-2029)
- 11.2.1 Global Opioids Drug Sales (K MT) Forecast by Application
- 11.2.2 Global Opioids Drug Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook